If data proving all that's been sprouted by Leslie, drops as intended by June 30th- We'll more than likely see a rerate in the share price, especially if there's a few more complete responses. Almost identical to that of November 2023.
If a licensing deal or outright sale of one of our products, creates revenue. Then we'll see share prices soar, as this creates viability and confidence.
Should neither of the above have been extensively explored and achieved by IMU management- Then this stock is about to either be so diluted, that 8 billion shares (current) will be only a fraction of holdings. Should capital raising be unsuccessful, then we're headed for the scrap heap and a fire sale.
It would take the most incompetent of any management to have not already visited and have some irons in the fire, with either remedy.
The eternal up rampers who probably believe in Santa & The Easter Bunny, will keep singing managements praises ( no need to mention those, as we all know who they are. Similarly those insisting on patients in requiring time for studies- we're simply out of juice ! Alternatively, those that constantly put the slipper in, might just need to see what unfolds.
If we only have funding till September, on what they spend and pay themselves - Sit back and see what hand they are holding, as they will need to show their cards either way, over the next month or two. TIMES UP !
Fingers crossed !!
-GO IMU!
Not Financial Advice - Opinions Only - DYOR!
IMU Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)